Space Summit Capital Exits Bellevue Life Sciences (BLACU) Position
Ticker: OSRHW · Form: SC 13G/A · Filed: Feb 5, 2024 · CIK: 1840425
| Field | Detail |
|---|---|
| Company | Bellevue Life Sciences Acquisition Corp. (OSRHW) |
| Form Type | SC 13G/A |
| Filed Date | Feb 5, 2024 |
| Risk Level | medium |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: institutional-ownership, insider-sell, spac, ownership-change
TL;DR
**Space Summit Capital just dumped all its BLACU shares.**
AI Summary
Space Summit Capital LLC, a Delaware-based entity, filed an amended SC 13G/A on February 5, 2024, indicating a significant change in its holdings of Bellevue Life Sciences Acquisition Corp. (BLACU) Units. As of December 31, 2023, Space Summit Capital LLC reported owning 0 shares with both sole and shared voting and dispositive power, down from a previous undisclosed beneficial ownership. This matters to investors because it signals that a major institutional holder has completely exited its position, which could be interpreted as a loss of confidence in the company's future or a strategic portfolio reallocation.
Why It Matters
This filing shows a significant institutional investor has sold all its shares, which could signal a lack of confidence in Bellevue Life Sciences Acquisition Corp.'s future prospects or a strategic shift in the investor's portfolio.
Risk Assessment
Risk Level: medium — The complete exit of an institutional investor can create selling pressure and signal potential underlying issues or a lack of future growth catalysts for the company.
Analyst Insight
A smart investor would investigate the reasons behind Space Summit Capital LLC's complete exit from Bellevue Life Sciences Acquisition Corp. (BLACU) and consider if this signals broader concerns about the company's future or its ability to complete a successful de-SPAC transaction.
Key Numbers
- 0 — Shares Beneficially Owned (Space Summit Capital LLC's aggregate beneficial ownership of Bellevue Life Sciences Acquisition Corp. Units as of December 31, 2023.)
- 79174207 — CUSIP Number (Identifies the specific class of securities (Units) of Bellevue Life Sciences Acquisition Corp. being reported on.)
Key Players & Entities
- Space Summit Capital LLC (company) — reporting person, exited its position in Bellevue Life Sciences Acquisition Corp.
- Bellevue Life Sciences Acquisition Corp. (company) — the issuer whose Units were reported on
- Delaware (company) — place of organization for Space Summit Capital LLC
- 0 (dollar_amount) — number of shares beneficially owned by Space Summit Capital LLC as of December 31, 2023
Forward-Looking Statements
- Bellevue Life Sciences Acquisition Corp. (BLACU) stock may experience increased selling pressure or a lack of institutional interest in the near term. (Bellevue Life Sciences Acquisition Corp.) — medium confidence, target: Q2 2024
FAQ
What is the purpose of this SC 13G/A filing?
This SC 13G/A filing is an amendment (Amendment No. 1) to a previous Schedule 13G, indicating a change in beneficial ownership of Bellevue Life Sciences Acquisition Corp. Units by Space Summit Capital LLC, specifically showing a complete divestment of their holdings.
Who is the reporting person in this filing?
The reporting person in this filing is Space Summit Capital LLC, a company organized in Delaware, with a business address at 15455 Albright Street, Pacific Palisades, CA 90272.
What is the aggregate amount of shares beneficially owned by Space Summit Capital LLC as of the event date?
As of December 31, 2023, Space Summit Capital LLC reported an aggregate amount of 0 shares beneficially owned, with 0 sole voting power, 0 shared voting power, 0 sole dispositive power, and 0 shared dispositive power.
What is the CUSIP number for the securities discussed in this filing?
The CUSIP number for the Units of Bellevue Life Sciences Acquisition Corp. is 79174207.
When was the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 5, 2024 regarding Bellevue Life Sciences Acquisition Corp. (OSRHW).